TENNESSEE RETINA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.tnretina.com/
Bringing It All Back Home: Reshaping Ophthalmology's Clinic with Home OCT
The FDA approved Notal Vision's home OCT device, Scanly, in May 2024 for monitoring retinal diseases like nAMD. Scanly uses spectral-domain OCT technology and an AI-based algorithm to estimate fluid volume, enabling efficient at-home monitoring. This innovation aligns with the introduction of longer-acting treatments, reducing patient treatment burden and enhancing personalized care.
© Copyright 2024. All Rights Reserved by MedPath